Delaware – Stock Epinephrine Law

Congratulations! Delaware has a stock epinephrine law in place, Chapter 342, which amends Title 16 of the Delaware Code relating to emergency medication in schools.  This law was signed by Governor Markell on July 21, 2014.

However, our job is not done yet. Each law or regulation must be implemented or put into action by a board or an agency.

Allergy & Asthma Network supports stock epinephrine implementation in schools and provides education and resources to support a seamless rollout. For more information, visit:

See below to find an ACE team in Delaware. Questions? Contact Brenda Silvia-Torma

Visit our Online Advocacy Center to find out about other current federal and state issues of importance to people with asthma or allergies.

 ACE Teams:

Michelle Baker, RN of Lord Baltimore Elementary School
Ocean View, DE

Denise Kalman, DO with Crozer-Keystone Health System
Upland, PA

ACE Team Activities:

Dr. Kalman
 has completed many advocacy activities, including obtaining stock epinephrine for schools and advocating for passage of evidence-based anaphylaxis-related legislation. She impacted legislation in both Pennsylvania and Delaware, changed anaphylaxis policies and procedures, and increased anaphylaxis awareness. Delaware’s stock epinephrine bill passed in record time: 13 days from introduction to landing on the Governor’s desk.

Questions about state legislation, ACE activities or getting involved?


About Anaphylaxis Community Experts (ACEs):
Anaphylaxis Community Experts is a national, award-winning education, advocacy and outreach partnership program developed and hosted by The Network and the American College of Allergy, Asthma & Immunology, sponsored by Mylan Specialty L.P.

Back to the USAnaphylaxis Map

We want to keep you informed on the latest recommendations on how to stay safe and healthy during this pandemic. Please visit our COVID-19  Information Center, updated daily.

You have Successfully Subscribed!